CTI BioPharma Meets One Of Two Endpoints In Phase 3 Trial
August 29, 2016 at 13:35 PM EDT
CTI BioPharma Corp. (NASDAQ: CTIC) shares are trading higher on Monday after the company announced its preliminary results of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.